157 related articles for article (PubMed ID: 18784736)
1. Hypertensive women with the metabolic syndrome are at risk of renal insufficiency more than men in general population.
Korhonen P; Aarnio P; Vesalainen R; Saaresranta T; Kautiainen H; Järvenpää S; Kantola I
J Hum Hypertens; 2009 Feb; 23(2):97-104. PubMed ID: 18784736
[TBL] [Abstract][Full Text] [Related]
2. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
Hildrum B; Mykletun A; Hole T; Midthjell K; Dahl AA
BMC Public Health; 2007 Aug; 7():220. PubMed ID: 17727697
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of renal insufficiency in individuals with hypertension and obesity/overweight: the FATH study.
Gomez P; Ruilope LM; Barrios V; Navarro J; Prieto MA; Gonzalez O; Guerrero L; Zamorano MA; Filozof C;
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S194-200. PubMed ID: 17130261
[TBL] [Abstract][Full Text] [Related]
4. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.
See LC; Kuo CF; Chuang FH; Li HY; Chen YM; Chen HW; Yu KH
J Rheumatol; 2009 Aug; 36(8):1691-8. PubMed ID: 19531754
[TBL] [Abstract][Full Text] [Related]
5. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy.
Cordero A; Laclaustra M; León M; Grima A; Casasnovas JA; Luengo E; del Rio A; Ferreira I; Alegria E
Am J Hypertens; 2006 Feb; 19(2):189-96; discussion 197-8. PubMed ID: 16448891
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
Fiuza M; Cortez-Dias N; Martins S; Belo A;
Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.
Ryu S; Chang Y; Woo HY; Lee KB; Kim SG; Kim DI; Kim WS; Suh BS; Jeong C; Yoon K
Am J Kidney Dis; 2009 Jan; 53(1):59-69. PubMed ID: 18838200
[TBL] [Abstract][Full Text] [Related]
8. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
[TBL] [Abstract][Full Text] [Related]
9. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice.
Barrios V; Escobar C; Murga N; de Pablo C; Bertomeu V; Calderón A; Echarri R
J Hypertens; 2008 Nov; 26(11):2230-5. PubMed ID: 18854765
[TBL] [Abstract][Full Text] [Related]
10. [Renal function and cardiovascular risk in patients with essential hypertension. The "FRESHA" study].
Herrero P; Marín R; Fernández Vega F; Gorostidi M; Riesgo A; Vázquez J; Díez Ojeda B;
Nefrologia; 2006; 26(3):330-8. PubMed ID: 16892821
[TBL] [Abstract][Full Text] [Related]
11. The metabolic syndrome and risk of myocardial infarction in familial hypertension (hypertension heredity in Malmö evaluation study).
Fedorowski A; Burri P; Hulthén L; Melander O
J Hypertens; 2009 Jan; 27(1):109-17. PubMed ID: 19050451
[TBL] [Abstract][Full Text] [Related]
12. Renal dysfunction predicts attenuation of ischemic heart disease mortality risk from elevated glucose among treated hypertensive patients.
Hailpern SM; Cohen HW; Alderman MH
Am J Hypertens; 2006 Oct; 19(10):998-1004. PubMed ID: 17027817
[TBL] [Abstract][Full Text] [Related]
13. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of chronic kidney disease in La Réunion island and its association with the metabolic syndrome in the non-diabetic population: La Réunion Diabetes (REDIA) Study.
Stengel B; Jaussent I; Guiserix J; Bourgeon B; Papoz L; Favier F;
Diabetes Metab; 2007 Dec; 33(6):444-52. PubMed ID: 18006351
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults.
Kurella M; Lo JC; Chertow GM
J Am Soc Nephrol; 2005 Jul; 16(7):2134-40. PubMed ID: 15901764
[TBL] [Abstract][Full Text] [Related]
16. Urinary albumin excretion and glomerular filtration rate across the spectrum of glucose abnormalities in essential hypertension.
Redon J; Morales-Olivas F; Galgo A; Brito MA; Mediavilla J; Marín R; Rodríguez P; Tranche S; Lozano JV; Filozof C;
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S236-45. PubMed ID: 17130268
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.
Li WJ; Xue H; Sun K; Song XD; Wang YB; Zhen YS; Han YF; Hui RT
Chin Med J (Engl); 2008 Aug; 121(16):1532-6. PubMed ID: 18985935
[TBL] [Abstract][Full Text] [Related]
18. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
[TBL] [Abstract][Full Text] [Related]
19. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study.
Navarro J; Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Bonet A; González-Esteban J
Blood Press; 2007; 16(1):20-7. PubMed ID: 17453748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
